BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

484 related articles for article (PubMed ID: 28539470)

  • 1. The Src/c-Abl pathway is a potential therapeutic target in amyotrophic lateral sclerosis.
    Imamura K; Izumi Y; Watanabe A; Tsukita K; Woltjen K; Yamamoto T; Hotta A; Kondo T; Kitaoka S; Ohta A; Tanaka A; Watanabe D; Morita M; Takuma H; Tamaoka A; Kunath T; Wray S; Furuya H; Era T; Makioka K; Okamoto K; Fujisawa T; Nishitoh H; Homma K; Ichijo H; Julien JP; Obata N; Hosokawa M; Akiyama H; Kaneko S; Ayaki T; Ito H; Kaji R; Takahashi R; Yamanaka S; Inoue H
    Sci Transl Med; 2017 May; 9(391):. PubMed ID: 28539470
    [TBL] [Abstract][Full Text] [Related]  

  • 2. c-Abl inhibition delays motor neuron degeneration in the G93A mouse, an animal model of amyotrophic lateral sclerosis.
    Katsumata R; Ishigaki S; Katsuno M; Kawai K; Sone J; Huang Z; Adachi H; Tanaka F; Urano F; Sobue G
    PLoS One; 2012; 7(9):e46185. PubMed ID: 23049975
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA damage accumulates and responses are engaged in human ALS brain and spinal motor neurons and DNA repair is activatable in iPSC-derived motor neurons with SOD1 mutations.
    Kim BW; Jeong YE; Wong M; Martin LJ
    Acta Neuropathol Commun; 2020 Jan; 8(1):7. PubMed ID: 32005289
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A cellular model for sporadic ALS using patient-derived induced pluripotent stem cells.
    Burkhardt MF; Martinez FJ; Wright S; Ramos C; Volfson D; Mason M; Garnes J; Dang V; Lievers J; Shoukat-Mumtaz U; Martinez R; Gai H; Blake R; Vaisberg E; Grskovic M; Johnson C; Irion S; Bright J; Cooper B; Nguyen L; Griswold-Prenner I; Javaherian A
    Mol Cell Neurosci; 2013 Sep; 56():355-64. PubMed ID: 23891805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coactivation of GSK3β and IGF-1 Attenuates Amyotrophic Lateral Sclerosis Nerve Fiber Cytopathies in SOD1 Mutant Patient-Derived Motor Neurons.
    Ting HC; Yang HI; Harn HJ; Chiu IM; Su HL; Li X; Chen MF; Ho TJ; Liu CA; Tsai YJ; Chiou TW; Lin SZ; Chang CY
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered calcium dynamics and glutamate receptor properties in iPSC-derived motor neurons from ALS patients with C9orf72, FUS, SOD1 or TDP43 mutations.
    Bursch F; Kalmbach N; Naujock M; Staege S; Eggenschwiler R; Abo-Rady M; Japtok J; Guo W; Hensel N; Reinhardt P; Boeckers TM; Cantz T; Sterneckert J; Van Den Bosch L; Hermann A; Petri S; Wegner F
    Hum Mol Genet; 2019 Sep; 28(17):2835-2850. PubMed ID: 31108504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. C9orf72 Hexanucleotide Expansions Are Associated with Altered Endoplasmic Reticulum Calcium Homeostasis and Stress Granule Formation in Induced Pluripotent Stem Cell-Derived Neurons from Patients with Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Dafinca R; Scaber J; Ababneh N; Lalic T; Weir G; Christian H; Vowles J; Douglas AG; Fletcher-Jones A; Browne C; Nakanishi M; Turner MR; Wade-Martins R; Cowley SA; Talbot K
    Stem Cells; 2016 Aug; 34(8):2063-78. PubMed ID: 27097283
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathological Modification of TDP-43 in Amyotrophic Lateral Sclerosis with SOD1 Mutations.
    Jeon GS; Shim YM; Lee DY; Kim JS; Kang M; Ahn SH; Shin JY; Geum D; Hong YH; Sung JJ
    Mol Neurobiol; 2019 Mar; 56(3):2007-2021. PubMed ID: 29982983
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Motor neurons from ALS patients with mutations in C9ORF72 and SOD1 exhibit distinct transcriptional landscapes.
    Wong CO; Venkatachalam K
    Hum Mol Genet; 2019 Aug; 28(16):2799-2810. PubMed ID: 31107959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Drug screening for ALS using patient-specific induced pluripotent stem cells.
    Egawa N; Kitaoka S; Tsukita K; Naitoh M; Takahashi K; Yamamoto T; Adachi F; Kondo T; Okita K; Asaka I; Aoi T; Watanabe A; Yamada Y; Morizane A; Takahashi J; Ayaki T; Ito H; Yoshikawa K; Yamawaki S; Suzuki S; Watanabe D; Hioki H; Kaneko T; Makioka K; Okamoto K; Takuma H; Tamaoka A; Hasegawa K; Nonaka T; Hasegawa M; Kawata A; Yoshida M; Nakahata T; Takahashi R; Marchetto MC; Gage FH; Yamanaka S; Inoue H
    Sci Transl Med; 2012 Aug; 4(145):145ra104. PubMed ID: 22855461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid and Robust Multi-Phenotypic Assay System for ALS Using Human iPS Cells with Mutations in Causative Genes.
    Kondo T; Ebinuma I; Tanaka H; Nishikawa Y; Komiya T; Ishikawa M; Okano H
    Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microphysiological 3D model of amyotrophic lateral sclerosis (ALS) from human iPS-derived muscle cells and optogenetic motor neurons.
    Osaki T; Uzel SGM; Kamm RD
    Sci Adv; 2018 Oct; 4(10):eaat5847. PubMed ID: 30324134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modeling ALS with iPSCs reveals that mutant SOD1 misregulates neurofilament balance in motor neurons.
    Chen H; Qian K; Du Z; Cao J; Petersen A; Liu H; Blackbourn LW; Huang CL; Errigo A; Yin Y; Lu J; Ayala M; Zhang SC
    Cell Stem Cell; 2014 Jun; 14(6):796-809. PubMed ID: 24704493
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enhancing NAD+ Salvage Pathway Reverts the Toxicity of Primary Astrocytes Expressing Amyotrophic Lateral Sclerosis-linked Mutant Superoxide Dismutase 1 (SOD1).
    Harlan BA; Pehar M; Sharma DR; Beeson G; Beeson CC; Vargas MR
    J Biol Chem; 2016 May; 291(20):10836-46. PubMed ID: 27002158
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Downstream Effects of Mutations in
    Dash BP; Freischmidt A; Weishaupt JH; Hermann A
    Int J Mol Sci; 2022 Aug; 23(17):. PubMed ID: 36077049
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The small heat shock protein B8 (HspB8) promotes autophagic removal of misfolded proteins involved in amyotrophic lateral sclerosis (ALS).
    Crippa V; Sau D; Rusmini P; Boncoraglio A; Onesto E; Bolzoni E; Galbiati M; Fontana E; Marino M; Carra S; Bendotti C; De Biasi S; Poletti A
    Hum Mol Genet; 2010 Sep; 19(17):3440-56. PubMed ID: 20570967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tar DNA binding protein of 43 kDa (TDP-43), 14-3-3 proteins and copper/zinc superoxide dismutase (SOD1) interact to modulate NFL mRNA stability. Implications for altered RNA processing in amyotrophic lateral sclerosis (ALS).
    Volkening K; Leystra-Lantz C; Yang W; Jaffee H; Strong MJ
    Brain Res; 2009 Dec; 1305():168-82. PubMed ID: 19815002
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Co-deposition of SOD1, TDP-43 and p62 proteinopathies in ALS: evidence for multifaceted pathways underlying neurodegeneration.
    Trist BG; Fifita JA; Hogan A; Grima N; Smith B; Troakes C; Vance C; Shaw C; Al-Sarraj S; Blair IP; Double KL
    Acta Neuropathol Commun; 2022 Aug; 10(1):122. PubMed ID: 36008843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Overexpressed wild-type superoxide dismutase 1 exhibits amyotrophic lateral sclerosis-related misfolded conformation in induced pluripotent stem cell-derived spinal motor neurons.
    Komatsu K; Imamura K; Yamashita H; Julien JP; Takahashi R; Inoue H
    Neuroreport; 2018 Jan; 29(1):25-29. PubMed ID: 29140847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TDP-43 is consistently co-localized with ubiquitinated inclusions in sporadic and Guam amyotrophic lateral sclerosis but not in familial amyotrophic lateral sclerosis with and without SOD1 mutations.
    Maekawa S; Leigh PN; King A; Jones E; Steele JC; Bodi I; Shaw CE; Hortobagyi T; Al-Sarraj S
    Neuropathology; 2009 Dec; 29(6):672-83. PubMed ID: 19496940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.